Zomedica Corp. Files Proxy Materials
Ticker: ZOMDF · Form: DEFA14A · Filed: Jun 6, 2025 · CIK: 1684144
| Field | Detail |
|---|---|
| Company | Zomedica Corp. (ZOMDF) |
| Form Type | DEFA14A |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
TL;DR
Zomedica proxy filing is out, shareholders vote soon.
AI Summary
Zomedica Corp. filed a Definitive Additional Materials proxy statement on June 6, 2025, related to its annual meeting. The company, previously known as Zomedica Pharmaceuticals Corp., is headquartered in Ann Arbor, Michigan, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is important for shareholders as it contains information related to voting and corporate governance decisions for Zomedica Corp.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would inherently increase risk.
Key Players & Entities
- Zomedica Corp. (company) — Registrant
- Zomedica Pharmaceuticals Corp. (company) — Former company name
- Ann Arbor, Michigan (location) — Company headquarters
- June 6, 2025 (date) — Filing date
- May 29, 2025 (date) — Date proxy materials were sent
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement filed by Zomedica Corp. with the SEC.
When was this filing submitted to the SEC?
The filing was submitted on June 6, 2025.
What was Zomedica Corp.'s former name?
Zomedica Corp.'s former name was Zomedica Pharmaceuticals Corp., with a name change date of September 8, 2016.
Where is Zomedica Corp. located?
Zomedica Corp. is located at 100 Phoenix Drive, Suite 125, Ann Arbor, MI 48108.
What is Zomedica Corp.'s fiscal year end?
Zomedica Corp.'s fiscal year ends on December 31.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 6, 2025 regarding Zomedica Corp. (ZOMDF).